Date: 05/29/2009
Length: 00:11:46
Size: 5.38MB
Thought Leaders: Lawrence Reiter, Ph.D., Director of Global Affairs, Criterium Inc.
Dr. Reiter discusses why it’s important to maintain R&D spending during fiscally challenging times, the pros and cons of a global R&D plan, how to do more with less, what technology brings to the table, and other critical factors to improve the development process.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Tuesday, June 09, 2009
Charting a New Course by Catalyzing Transformation
Date: 05/28/2009
Length: 00:14:56
Size: 6.84MB
Thought Leaders: Adrian McKemey, Ph.D. Managing Director, Quintiles Consulting
Michael Arlotto, Ph.D., Senior Vice President, Quintiles Corporate Development.
In episode three, of a three-part series, “Surviving to Thriving in Stormy Weather,” our thought leaders discuss declining R & D productivity combined with increasing development costs. They offer insights and solutions to maximizing efficiencies and effecting change within R & D organizations in the biopharma industry.
Play Podcast
Download Related Whitepaper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:14:56
Size: 6.84MB
Thought Leaders: Adrian McKemey, Ph.D. Managing Director, Quintiles Consulting
Michael Arlotto, Ph.D., Senior Vice President, Quintiles Corporate Development.
In episode three, of a three-part series, “Surviving to Thriving in Stormy Weather,” our thought leaders discuss declining R & D productivity combined with increasing development costs. They offer insights and solutions to maximizing efficiencies and effecting change within R & D organizations in the biopharma industry.
Play Podcast
Download Related Whitepaper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
How to Connect Patients and Physicians Around Your Brand
Date: 05/27/2009
Length: 00:17:57
Size: 8.22MB
Thought Leaders: Michael Ball, Ph.D., VP of Marketing, InfoMedics
Paul LeVine, VP of Analytical Services, InfoMedics
In this episode, Dr. Ball and Mr. LeVine discuss the importance of patient feedback – how to obtain it and how it can be used to better connect brands with patients and physicians in a practice setting.
Play Podcast
Download Related Whitepaper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:17:57
Size: 8.22MB
Thought Leaders: Michael Ball, Ph.D., VP of Marketing, InfoMedics
Paul LeVine, VP of Analytical Services, InfoMedics
In this episode, Dr. Ball and Mr. LeVine discuss the importance of patient feedback – how to obtain it and how it can be used to better connect brands with patients and physicians in a practice setting.
Play Podcast
Download Related Whitepaper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Connecting through Electronic Health Records
Date: 05/26/2009
Length: 00:14:41
Size: 6.72MB
Thought Leaders: Landen Bain, Liaison to Healthcare, CDISC
Dave Iberson-Hurst, VP of Technical Strategy, CDISC
In this episode, Mr. Bain and Mr. Iberson-Hurst discuss CDISC’s efforts in instituting standards for Electronic Health Records and RFD - Retrieve Form for Data Capture. They also cover where the organization’s efforts will be applied in the future.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:14:41
Size: 6.72MB
Thought Leaders: Landen Bain, Liaison to Healthcare, CDISC
Dave Iberson-Hurst, VP of Technical Strategy, CDISC
In this episode, Mr. Bain and Mr. Iberson-Hurst discuss CDISC’s efforts in instituting standards for Electronic Health Records and RFD - Retrieve Form for Data Capture. They also cover where the organization’s efforts will be applied in the future.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Making Headway in Shifting Winds by Maximizing Value
Date: 5/01/2009
Length: 00:19:08
Size: 8.76MB
Thought Leaders: James Featherstone, Ph.D., VP of Product Development and Commercialization for the EU, Quintiles Consulting, Bruce E. Johnson, Ph.D., Senior Research Director, Eidetics, a division of Quintiles Consulting, and Heidi Hunter, Global VP, Business Development, Quintiles
In episode two, of a three-part series, "Surviving to Thriving in Stormy Weather," our thought leaders discuss new commercialization processes as healthcare moves towards personalized medicine. They also cover how to assess market potential for personalized therapies, post-launch sales strategies for niche drugs, and finally, meeting the needs of global and regional markets for these types of therapies.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Length: 00:19:08
Size: 8.76MB
Thought Leaders: James Featherstone, Ph.D., VP of Product Development and Commercialization for the EU, Quintiles Consulting, Bruce E. Johnson, Ph.D., Senior Research Director, Eidetics, a division of Quintiles Consulting, and Heidi Hunter, Global VP, Business Development, Quintiles
In episode two, of a three-part series, "Surviving to Thriving in Stormy Weather," our thought leaders discuss new commercialization processes as healthcare moves towards personalized medicine. They also cover how to assess market potential for personalized therapies, post-launch sales strategies for niche drugs, and finally, meeting the needs of global and regional markets for these types of therapies.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157
Subscribe to:
Posts (Atom)